R&D | November 23, 2025
Rafa Laboratories lands $186 million BARDA contract to develop life-saving trauma drug
Landmark studies have shown that rapid TXA administration can significantly reduce mortality
Landmark studies have shown that rapid TXA administration can significantly reduce mortality
The X CUBE 50 integrates ALPINION’s advanced X+ Architecture
The study successfully met its primary endpoint, demonstrating similar rates of viral suppression for DOR/ISL compared to Biktarvy at 48 weeks
This is the first and only subcutaneous immune checkpoint inhibitor available in Europe
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing
This strategic initiative aims to accelerate proof-of-concept of pipeline assets by streamlining R&D operations
This marks Lupin’s first commercial product leveraging PrecisionSphere, a proprietary long-acting injectable (LAI) technology
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
Subscribe To Our Newsletter & Stay Updated
